tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

QNCX Stock Latest News

Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/3/26
Market NewsVanguard Total Stock Market ETF (VTI) Daily Snapshot—2/3/26
11h ago
L
CLB
Quince Therapeutics Announces Significant Board of Directors Resignations
PremiumCompany Announcements
Quince Therapeutics Announces Significant Board of Directors Resignations
1d ago
8K
QNCX
Vanguard Total Stock Market ETF (VTI) Daily Update—2/2/26
PremiumMarket News
Vanguard Total Stock Market ETF (VTI) Daily Update—2/2/26
1d ago
L
CLB
Quince Therapeutics downgraded to Sell from Buy at Lucid Capital (earlier)
PremiumThe Fly
Quince Therapeutics downgraded to Sell from Buy at Lucid Capital (earlier)
4d ago
QNCX
Quince Therapeutics downgraded to Hold from Buy at Maxim
PremiumThe Fly
Quince Therapeutics downgraded to Hold from Buy at Maxim
4d ago
QNCX
Spotify upgraded, Pinterest downgraded: Wall Street’s top analyst calls
PremiumThe FlySpotify upgraded, Pinterest downgraded: Wall Street’s top analyst calls
4d ago
ALC
DGX
Vanguard VTI Daily Snapshot — Jan. 30
Premium
Market News
Vanguard VTI Daily Snapshot — Jan. 30
4d ago
CLB
IMA
Quince Therapeutics downgraded to Hold from Buy at D. Boral Capital
Premium
The Fly
Quince Therapeutics downgraded to Hold from Buy at D. Boral Capital
4d ago
QNCX
Citizens downgrades Quince Therapeutics on study failure
PremiumThe Fly
Citizens downgrades Quince Therapeutics on study failure
5d ago
QNCX
Quince Therapeutics downgraded to Market Perform from Outperform at Citizens
PremiumThe Fly
Quince Therapeutics downgraded to Market Perform from Outperform at Citizens
5d ago
QNCX
Quince Therapeutics down 88% after reopening for trading
PremiumThe Fly
Quince Therapeutics down 88% after reopening for trading
5d ago
QNCX
Quince Therapeutics trading resumes
PremiumThe Fly
Quince Therapeutics trading resumes
5d ago
QNCX
Quince down 14% after NEAT study endpoint did not reach statistical significance
PremiumThe FlyQuince down 14% after NEAT study endpoint did not reach statistical significance
5d ago
QNCX
Quince Therapeutics to cease clinical development of eDSP
Premium
The Fly
Quince Therapeutics to cease clinical development of eDSP
5d ago
QNCX
Quince Therapeutics says Phase 3 NEAT trial of eDSP did not meet endpoints
Premium
The Fly
Quince Therapeutics says Phase 3 NEAT trial of eDSP did not meet endpoints
5d ago
QNCX
Quince Therapeutics trading halted, news pending
PremiumThe Fly
Quince Therapeutics trading halted, news pending
5d ago
QNCX
Quince Therapeutics presents Ataxia-Telangiectasia treatment data
PremiumThe Fly
Quince Therapeutics presents Ataxia-Telangiectasia treatment data
6d ago
QNCX
Quince Therapeutics participates in a conference call with Citizens
PremiumThe Fly
Quince Therapeutics participates in a conference call with Citizens
1M ago
QNCX
Quince Therapeutics price target raised to $5 from $4 at D. Boral Capital
PremiumThe Fly
Quince Therapeutics price target raised to $5 from $4 at D. Boral Capital
2M ago
QNCX
Quince Therapeutics announces last visit from last patient in NEAT trial
PremiumThe FlyQuince Therapeutics announces last visit from last patient in NEAT trial
2M ago
QNCX
Quince Therapeutics publishes summary of early-stage clinical studies of eDSP
Premium
The Fly
Quince Therapeutics publishes summary of early-stage clinical studies of eDSP
2M ago
QNCX
Promising Outlook for Quince Therapeutics: Phase 3 Study and Innovative Platform Drive Buy Recommendation
Premium
Ratings
Promising Outlook for Quince Therapeutics: Phase 3 Study and Innovative Platform Drive Buy Recommendation
3M ago
QNCX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >